Opportunity
Simpler Grants.gov #PAR-25-170
NIH Solicitation for Digital Health Technology Biomarker and Outcome Assessment Development
Buyer
National Institutes of Health
Posted
November 13, 2024
Respond By
June 22, 2026
Identifier
PAR-25-170
NAICS
541715, 541714
The National Institutes of Health (NIH) is seeking proposals to advance digital health technology (DHT) biomarkers and outcome assessments for use in clinical trials. - Government Buyer: - National Institutes of Health (NIH) - Includes programs in Aging Research, Neurosciences and Neurological Disorders, and Cancer Control - Products/Services Requested: - Development and testing of digital health technology-derived biomarkers and clinical outcome assessments - Solutions must be validated in populations from at least three different diseases or conditions - Mandatory partnership with non-profit patient advocacy organizations - Unique/Notable Requirements: - No specific OEMs, vendors, or part numbers are specified - Open to a broad range of applicants: nonprofits, businesses, government entities, and educational institutions - Funding is through a cooperative agreement; no cost sharing or matching required - OEMs: - No OEMs or specific technology vendors are named in this opportunity
Description
This Notice of Funding Announcement (NOFO) supports the development of biomarkers or clinical outcomes derived from digital health technology for use in clinical trials as primary or secondary endpoints. Applicants must develop and test these assessments in populations from at least three different diseases or conditions to improve clinical impact, increase statistical feasibility, and promote standardization. Partnerships with non-profit patient advocacy organizations are required. The funding instrument is a cooperative agreement with no cost sharing or matching requirement.